: Glaxo to invest in German vaccine maker CureVac
GlaxoSmithKline on Monday said it was taking a stake in German vaccines maker CureVac, the latest move by a major drugmaker to boost capabilities to fight pandemics.
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.